Adverse Events Monitoring Data And Medical Studies Have Identified Possible Increased Risk For Cardiovascular Problems Including Arrhythmias

 
SUMMARY: In the US, hydroxyzine-containing drugs include Atarax (Roerig, a division of Pfizer) and Vistaril (Pfizer Labs and Roerig, each a division of Pfizer).

In early May 2014 the European Medicines Agency’s (EMA’s) Pharmacovigilance Risk Assessment Committee (PRAC) announced it was reviewing the safety of hydroxyzine-containing medicines because of cardiac concerns.

We will watch for the results of this drug safety review in Europe concerning Atarax, Vistaril, and other hydroxyzine medications.

[Read this article in full at original source]